| 1 |
中华医学会呼吸病学分会.支气管哮喘防治指南（2024年版）[J].中华结核和呼吸杂志，2025，48（3）：208-248.
|
| 2 |
中华医学会呼吸病学分会哮喘学组，中国哮喘联盟.支气管哮喘急性发作评估及处理中国专家共识[J].中华内科杂志，2018，57（1）：4-14.
|
| 3 |
Global Initiative for Asthma. Global strategy for asthma management and prevention, 2024[EB/OL]. (2024-05-16) [2025-11-01].
URL
|
| 4 |
林江涛，祝墡珠，王家骥，等.中国支气管哮喘防治指南（基层版）[J].中国实用内科杂志，2013，33（8）：615-622.
|
| 5 |
陈冰燕，徐美丽，李超乾.支气管哮喘急诊诊治及困惑[J].中华危重病急救医学，2025，37（5）：413-415.
|
| 6 |
Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests[J]. Eur Respir J, 2022, 60 (1): 2101499.
|
| 7 |
Xu J, Tian L, Han X. Successful treatment of near-fatal asthma with ECMO: a case report and literature review[J]. Int J Artif Organs, 2023, 46 (8-9): 532-536.
|
| 8 |
中华医学会变态反应学分会. 2型炎症性疾病机制及靶向治疗专家共识[J].中华医学杂志，2022，102（42）：3349-3373.
|
| 9 |
Global Initiative for Asthma. Global Strategy for asthma management and prevention, 2019[EB/OL]. (2019-10-15) [2025-11-01].
URL
|
| 10 |
中国医药教育协会慢性气道疾病专业委员会，中国哮喘联盟.重度哮喘诊断与处理中国专家共识（2024）[J].中华医学杂志，2024，104（20）：1759-1789.
|
| 11 |
Zhang Q, Fu X, Wang C, et al. Severe eosinophilic asthma in Chinese C-BIOPRED asthma cohort[J]. Clin Transl Med, 2022, 12 (2): e710.
|
| 12 |
Deng Z, Jin M, Ou C, et al. Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies[J]. Chin Med J (Engl), 2023, 136 (2): 230-232.
|
| 13 |
Walsh CJ, Zaihra T, Benedetti A, et al. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils[J]. Clin Exp Allergy, 2016, 46 (10): 1291-1302.
|
| 14 |
Celis-Preciado C, Leclerc S, Duval M, et al. Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)[J]. Eur Respir J, 2025, 65 (5): 2402391.
|
| 15 |
Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J]. Lancet, 2019, 394 (10196): 407-418.
|
| 16 |
Deng X, Ma J, Yuan Y, et al. Association between overweight or obesity and the risk for childhood asthma and wheeze: an updated meta-analysis on 18 articles and 73 252 children[J]. Pediatr Obes, 2019, 14 (9): e12532.
|
| 17 |
Barrecheguren M, Pinto L, Mostafavi-Pour-Manshadi SM, et al. Identification and definition of asthma-COPD overlap: the CanCOLD study[J]. Respirology, 2020, 25 (8): 836-849.
|
| 18 |
赵燕霞，丛立，开赛尔·艾则孜，等.支气管哮喘合并胃食管反流病相关危险因素分析[J/OL].中华胃食管反流病电子杂志，2020，7（3）：150-153.
|
| 19 |
王文雅，林江涛，周新，等.我国> 14岁重症哮喘患者的临床特征和患病危险因素[J].中华医学杂志，2020，100（14）：1106-1111.
|
| 20 |
Ye G, Baldwin DS, Hou R. Anxiety in asthma: a systematic review and meta-analysis[J]. Psychol Med, 2021, 51 (1): 11-20.
|
| 21 |
陈腊青，林佳佳，毛洪刚，等.血清细胞因子及呼出气一氧化氮在哮喘-慢性阻塞性肺疾病重叠综合征中的临床意义[J/OL].中华危重症医学杂志（电子版），2023，16（4）：316-320.
|
| 22 |
Rajvanshi N, Kumar P, Goyal JP. Global initiative for asthma guidelines 2024: an update[J]. Indian Pediatr, 2024, 61 (8): 781-786.
|
| 23 |
Soremekun S, Heaney LG, Skinner D, et al. Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study[J]. Thorax, 2023, 78 (7): 643-652.
|
| 24 |
急诊氧气治疗专家共识组.急诊氧气治疗专家共识[J].中华急诊医学杂志，2018，27（4）：355-360.
|
| 25 |
李超乾，张剑锋，黄霜霞，等.基层院前急救基本要求及流程规范[J].中华急诊医学杂志，2020，29（7）：996-999.
|
| 26 |
Gao Y, Liang B, Su X, et al. Reliability and usability of a portable spirometer compared to a laboratory spirometer[J]. BMC Pulm Med, 2025, 25 (1): 228.
|
| 27 |
Liu T, Woodruff PG, Zhou X. Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies[J]. Eur Respir J, 2024, 64 (2): 2300826.
|
| 28 |
LaForce C, Albers F, Danilewicz A, et al. As-needed albuterol-budesonide in mild asthma[J]. N Engl J Med, 2025, 393 (2): 113-124.
|
| 29 |
Rayner DG, Ferri DM, Guyatt GH, et al. Inhaled reliever therapies for asthma: a systematic review and meta-analysis[J]. JAMA, 2025, 333 (2): 143-152.
|
| 30 |
钟枝梅，王增睿，柒胜，等.硫酸镁治疗成人急性重度哮喘患者的有效性和安全性：一项Meta分析[J].中华危重病急救医学，2024，36（12）：1256-1260.
|
| 31 |
Javor E, Grle SP. Limitations of the results from randomized clinical trials involving intravenous and nebulised magnesium sulphate in adults with severe acute asthma[J]. Pulm Pharmacol Ther, 2019, 55: 31-37.
|
| 32 |
Johnson MD, Zorc JJ, Nelson DS, et al. Intravenous magnesium in asthma pharmacotherapy: variability in use in the PECARN registry[J]. J Pediatr, 2020, 220: 165-174.e2.
|
| 33 |
Rao R, Mei J, Chen H, et al. Association of metformin use with asthma development and adverse outcomes: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2024, 103 (40): e39785.
|
| 34 |
于海洋，陈云志，刘怀全，等.二甲双胍干预哮喘作用机制的研究进展[J].中国病理生理杂志，2021，37（4）：764-768.
|
| 35 |
Uppal P, Mohammed SA, Rajashekar S, et al. Type 2 diabetes mellitus and asthma: pathomechanisms of their association and clinical implications[J]. Cureus, 2023, 15 (3): e36047.
|
| 36 |
邓玉英，唐华平，毛琦善，等.半胱氨酰白三烯与呼吸系统疾病的研究进展[J].中国呼吸与危重监护杂志，2020，19（3）：291-298.
|
| 37 |
Carr TF, Fajt ML, Kraft M, et al. Treating asthma in the time of COVID[J]. J Allergy Clin Immuno, 2023, 151 (4): 809-817.
|
| 38 |
Thomas D, Mcdonald VM, Stevens S, et al. Effect of azithromycin on asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomized, double-anonymized, placebo-controlled trial[J]. Chest, 2024, 166 (2): 262-270.
|
| 39 |
Adrish M, Akuthota P. Approach to non-type 2 asthma[J]. Respir Med, 2023, 216: 107327.
|
| 40 |
中国医师协会急诊医师分会，中华医学会急诊医学分会，中国急诊专科医联体，等.成人慢性气道炎症性疾病急症诊疗急诊专家共识[J].中国急救医学，2021，41（4）：277-284.
|
| 41 |
Li J, Fink JB, MacLoughlin R, et al. A narrative review on trans-nasal pulmonary aerosol delivery[J]. Crit Care, 2020, 24 (1): 506.
|
| 42 |
国家心血管疾病医疗质量控制中心专家委员会体外循环与体外生命支持专家工作组. 2022年中国体外生命支持医疗质量控制报告[J].中国循环杂志，2023，38（6）：613-620.
|
| 43 |
Lozano-Espinosa M, Antolín-Amérigo D, Riera J, et al. Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: a comprehensive review[J]. Respir Med, 2023, 215: 107246.
|
| 44 |
柳亚慧，时国朝.支气管哮喘的精准治疗[J].中国实用内科杂志，2020，40（5）：371-376.
|
| 45 |
Chaudhuri R, Rubin A, Sumino K, et al. Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials[J]. Lancet Respir Med, 2021, 9 (5): 457-466.
|